Horizon Pharma (HZNP) PT Raised to $38 at Morgan Stanley
Tweet
Share
E-mailGet Alerts HZNP Hot Sheet
Price: $116.30 --0%
Rating Summary:
10 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
10 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Morgan Stanley analyst David Risinger raised the price target on Horizon Pharma (NASDAQ: HZNP) to $38.00 (from $32.00) while maintaining a Overweight rating.
You May Also Be Interested In
- CIBC Upgrades National Bank of Canada (NA:CN) (NTIOF) to Outperformer
- Wesdome Gold Mines Ltd. (WDO:CN) (WDOFF) PT Raised to Cdn$40 at Desjardins
- Target (TGT) PT Raised to $185 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
